Insider Selling: Mettler-Toledo International, Inc. (NYSE:MTD) Director Sells 1,062 Shares of Stock

Key Points

• Mettler-Toledo International, Inc. Director Thomas P. Salice sold 1,062 shares at an average price of $1,300.90, resulting in a total sale value of approximately $1.38 million and a 78.96% decrease in his position.
• The company's stock price has risen slightly, trading at $1,313.88, with a market capitalization of $27.07 billion and a one-year high of $1,521.01.
• Mettler-Toledo reported strong earnings with an EPS of $10.09, which exceeded analyst expectations, contributing to a revenue increase of 3.9% compared to the previous year.

Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Mettler-Toledo International Stock Up 0.0%

Shares of NYSE:MTD traded up $0.24 during trading on Friday, hitting $1,313.88. 45,080 shares of the company traded hands, compared to its average volume of 174,526. The stock has a market capitalization of $27.07 billion, a price-to-earnings ratio of 33.27, a PEG ratio of 3.97 and a beta of 1.34. The business's fifty day moving average is $1,213.03 and its 200-day moving average is $1,190.73. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. The business's revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the company earned $9.65 earnings per share. On average, analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MTD. Vanguard Group Inc. boosted its stake in Mettler-Toledo International by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier's stock valued at $3,003,415,000 after purchasing an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Mettler-Toledo International by 71.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier's stock valued at $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of Mettler-Toledo International by 1.1% during the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier's stock valued at $842,802,000 after acquiring an additional 8,121 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Mettler-Toledo International by 0.6% in the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier's stock valued at $681,489,000 after purchasing an additional 3,383 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock valued at $568,032,000 after purchasing an additional 25,272 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on MTD shares. Bank of America raised their price target on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Evercore ISI dropped their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their price target for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price objective for the company from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Finally, Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and an average price target of $1,288.89.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.